More than €500 million in publicly reimbursed prescription drugs are destroyed in France every year after patients leave unused medications sitting in home medicine cabinets, according to a report by French television broadcaster TF1.
Figures highlighted by the network show that Assurance Maladie, France's national health insurance fund, pays out €517 million annually for prescription products that are returned to pharmacies and incinerated without ever being used.
Patients routinely bring their leftover treatments back to neighborhood pharmacies across France. However, under current regulations, the returned inventory is sent directly to waste facilities for high-temperature incineration, destroying public funds spent by the state.
The report featured individual accounts including Marie-Alix, a patient who accumulated years of surplus treatments in her home. Her unused storage included stockpiles of oral capsules, throat lozenges, and medicated creams that she no longer required for her health.
France's public healthcare and reimbursement system
Assurance Maladie operates as the national health insurance arm of France's social security system, known as Sécurité sociale. Funded through worker contributions and state taxation, the public agency covers a substantial portion of prescription medication costs for residents, aiming to ensure affordable healthcare access nationwide.
Under the French healthcare model, doctors prescribe treatments that pharmacists dispense in standardized manufacturer boxes rather than custom-counted quantities. Because patients receive pre-packaged boxes of capsules or blister packs, treatment changes or early recoveries frequently leave households with unused quantities.
When patients collect their prescribed medications from registered pharmacies, public insurance automatically reimburses the cost at the counter. Because the system covers millions of treatment packages each month, unused surplus accumulates rapidly in private homes across the country.
Why returned medications must be incinerated
French health safety protocols strictly forbid pharmacies from re-issuing returned medicines to other patients. Because safety authorities cannot verify whether returned drugs were stored at proper temperatures or kept free from contamination, all returned products must be incinerated as medical waste.
TF1 reported that incinerating these returned products effectively burns tax revenues collected by Sécurité sociale. The €517 million lost each year represents public funding that yields no medical benefit for patients or the broader healthcare system.
The report was prepared by the video news team at TF1info and broadcast on TF1's JT 13h weekday news program, a flagship afternoon bulletin that regularly reports on consumer issues, healthcare policy, and public spending in France.
